Iron Mountain Inc
—- Market cap
- —
- Debt
- —
- Cash
- −$158.54M
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: IRM stock price vs ACN: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at ACN's multiple
Needs ACN P/E.
Implied fair value · at IRM's multiple
Needs IRM P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
IRON MOUNTAIN INC · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Accenture plc · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
EQUINIX INC
IRM vs EQIX
Public Storage
IRM vs PSA
MAXIMUS, INC.
IRM vs MMS
ROLLINS INC
IRM vs ROL
CINTAS CORP
IRM vs CTAS
INTERNATIONAL BUSINESS MACHINES CORP
IRM vs IBM
COGNIZANT TECHNOLOGY SOLUTIONS CORP
IRM vs CTSH
DXC Technology Co
IRM vs DXC
Infosys Ltd
IRM vs INFY
MARSH & MCLENNAN COMPANIES, INC.
IRM vs MMC
ROBERT HALF INC.
IRM vs RHI
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe IRM can sustain 12.2% revenue growth and defend its 33.0% EBITDA margin without meaningful leverage deterioration, then maintain or add cautiously; if not, ACN looks far cheaper and higher quality on every standard valuation and profitability metric provided.
On a relative basis, IRM looks extremely expensive versus ACN: IRM trades at 249.6x P/E, 5.3x P/S, and 18.0x EV/EBITDA versus ACN at 13.7x, 1.5x, and 8.4x respectively. The model’s implied price of $6.69 versus IRM’s current price of $122.32 indicates a -94.5% downside on the P/E framework, but that output is likely driven by the very large earnings multiple gap rather than a like-for-like operating profile.
Supporting Metrics